Newsroom | NeoGenomics Laboratories

September 13, 2018

Clinicopathologic Characteristics and Novel Biomarkers of Aggressive B-Cell Lymphomas in the Nasopharynx

Literature

September 12, 2018

NeoGenomics Awarded Clinical Reference Laboratory Testing Services Agreement with Premier

Press Release

August 24, 2018

NeoGenomics Announces Proposed Public Offering of Common Stock

Press Release

August 9, 2018

NeoGenomics Announces Pricing on Public Offering of Common Stock

Press Release

August 6, 2018

NeoGenomics Announces Proposed Public Offering of Common Stock

Press Release

July 24, 2018

NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

Press Release

July 2, 2018

NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018

Press Release

June 25, 2018

NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock

Press Release

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients